Historical AI Consensus

This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.

Symbol: CS.PAR
Batch: 7
Published: September 20, 2026
AI Advisors: 14

Historical AI Consensus Investment Thesis

AXA (CS) Stock Forecast and AI Rating

Deep analysis published Sep 21 2026Original pricing snapshot Sep 18 2026

Publisher

Russlan Ramdowar

12 min read

Published 1-Year and 5-Year Forecast Outlook

Forecast targets and rating

Published batch rating

BUY

Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.

2027

1-Year

BUY

€49

+8.5%+13.1% incl. dividends

2031

5-Year

BUY

€65

+44.4%+77.4% incl. dividends

Published batch insight

Capital Return Discipline Outweighs Underwriting Friction Amid Sovereign Debt Spread Volatility

There is high consensus that higher fixed-income reinvestment yields and programmatic share buybacks underpin mid-single-digit per-share compounding, while sharp divergence persists over wholesale commercial pricing softness and French sovereign spread volatility. Solvency II capitalization provides structural defense against claims inflation.

Deep Forecast Analysis by iPulse AI Engine

This analysis preserves the original published batch. Audit published forecasts in full transparency

Warren Buffett (Value Purist), Universal Investor (Polymath), Michael Burry (Vulture), Elon Musk (Visionary), Machiavelli (Insider), Superintelligence (Anthropologist), J.P. Morgan (Titan), Ray Dalio (Strategist), Sherlock Holmes (Whistleblower). Some archetypes run in multiple modes, resulting in 14 advisors total.

Computed on these frontier AI models

Gemini

Claude

ChatGPT

Full published thesis

Executive Summary

If you invested $10,000 in AXA at the forecast anchor (2026-09-18): $18,453 in five years versus $13,892 for S&P 500 benchmark.

AXA · Synthesized ConsensusS&P 500 benchmark

* Return is calculated incl. 4.2% net dividend yield for AXA.

Figure: Five-year synthesized consensus value path for AXA compared with S&P 500 benchmark. The path uses the synthesizer’s normalized opinion weights.

20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each stepView table

Frozen forecast from 18 Sept 2026. Prices in EUR; returns exclude dividends. Each quarter is compounded from the previous quarter.

Anchor: 44.73 EUR1-year price return: +8.52%5-year price return: +44.39%

Swipe the table horizontally to read every column.

Twenty quarterly synthesized price forecasts in EUR, with returns and rationale
Quarter	Target (EUR)	Quarter return	Total return	Forecast rationale
Q4 2026	45.72	+2.21%	+2.21%	Initial market digestion of the multi-year strategic targets supports steady equity accumulation. Higher fixed-income reinvestment yields and ongoing open-market share buyback tranches absorb secondary market liquidity, offsetting autumn catastrophe claims and sovereign spread noise.
Q1 2027	47.46	+3.80%	+6.09%	Full-year financial reporting confirms underlying earnings per share progressing near the upper boundary of plan guidance. Management reinforces investor confidence by proposing an increased ordinary dividend and renewing annual share repurchase authorizations.
Q2 2027	47.04	-0.87%	+5.17%	Seasonal annual dividend detachment creates immediate technical downward pressure on the quoted share price. However, robust operational cash remittances and continuous corporate buyback execution partially cushion the drop, stabilizing trading across European exchanges.
Q3 2027	48.54	+3.19%	+8.52%	First-half disclosures demonstrate expanding net investment income as maturing bond portfolios roll over at higher benchmark yields. Disciplined technical pricing in retail and health protection offsets initial commercial rate softening.
Q4 2027	49.66	+2.30%	+11.02%	Solvency II capital surplus resilience supports year-end share repurchases, retiring equity and bolstering per-share intrinsic value. Conservative catastrophe reserving buffers balance-sheet own funds against unmodeled secondary weather peril volatility across Europe.
Q1 2028	51.45	+3.61%	+15.02%	Annual financial results validate sustained underlying return on equity within target bands. Solid organic cash upstreaming from operational subsidiaries enables another dividend increase, stimulating defensive value accumulation from institutional allocators.
Q2 2028	51.07	-0.74%	+14.17%	The quoted price absorbs mechanical drag from the annual dividend ex-date in May. Continued buyback execution and steady earnings accrual limit downside, while sovereign bond spread sensitivity moderates headline momentum.
Q3 2028	52.47	+2.74%	+17.30%	Mid-year results confirm measurable administrative cost compression from digital claims automation. Resilient health and employee protection underwriting compensates for persistent wholesale commercial property casualty pricing concessions.
Q4 2028	53.58	+2.12%	+19.78%	Reinvestment yields on long-term corporate credit and sovereign debt stabilize at attractive levels, bolstering net financial margins. Programmatic equity cancellations continue to reduce outstanding share count, supporting per-share value compounding.
Q1 2029	55.41	+3.41%	+23.87%	Full-year disclosures highlight underlying EPS compounding on schedule, backed by cumulative subsidiary cash remittances. Management reaffirms its 75% distribution commitment, driving selective institutional re-weighting toward high-yielding composite insurers.
Q2 2029	55.08	-0.59%	+23.14%	Mechanical ex-dividend price reductions dominate second-quarter trading action. Underlying underwriting profits remain protected by conservative risk selection, though cyclical rate softening prevents earnings accrual from fully neutralizing the distribution detachment.
Q3 2029	56.54	+2.65%	+26.41%	Interim reporting validates cumulative organic cash upstreaming tracking closely toward the 25-billion-euro target. Sustained technical margins across core European retail books underpin defensive stability during the late summer reporting window.
Q4 2029	57.76	+2.15%	+29.13%	Successful conclusion of the strategic cycle validates management credibility and balance sheet fortress design. Modest multiple re-anchoring reflects recognition of reduced operational volatility and sustained high-single-digit per-share compounding.
Q1 2030	59.57	+3.13%	+33.18%	Unveiling of the successor multi-year framework confirms ongoing commitment to high shareholder distributions. Operating capital generation above 25 points maintains Solvency II ratios well above operating floors, attracting steady institutional demand.
Q2 2030	59.15	-0.71%	+32.23%	Customary spring dividend detachment imposes technical price softening. Ongoing treasury share purchases absorb secondary supply, while life and health contractual service margin releases provide recurring baseline cash generation.
Q3 2030	60.43	+2.16%	+35.09%	Fixed-income portfolio turnover reaches maturity equilibrium, locking in higher recurring investment income. Strong retail customer retention and automated claims processing preserve operating leverage against sticky replacement-cost inflation.
Q4 2030	61.68	+2.08%	+37.90%	Prudent casualty claims reserving and disciplined catastrophe attachment structures safeguard year-end performance. Cumulative float reduction continues to mechanically enhance per-share metrics into the final trading weeks of the decade.
Q1 2031	63.50	+2.94%	+41.95%	Annual financial statements demonstrate a fifth consecutive year of meeting underlying return on equity targets. A further increase in regular dividends catalyzes fresh buying interest ahead of the spring shareholder meeting.
Q2 2031	63.17	-0.52%	+41.22%	The annual dividend detachment creates the expected seasonal dip in spot share prices. Steady underlying book value accretion and disciplined underwriting risk selection maintain the stock's defensive valuation floor.
Q3 2031	64.59	+2.25%	+44.39%	Terminal forecast interval confirms successful transformation into a capital-light, high-return composite insurer. Elevated running yields, reduced share float, and pristine Solvency II capitalization deliver durable long-term intrinsic value creation.

AXA represents a restructured, capital-light technical insurance compounder where per-share value creation decouples from top-line macro expansion. The fundamental investment thesis rests on an accelerating double engine: compounding net investment spreads as fixed-income float rolls over at structurally elevated bond yields, alongside systematic share cancellations that mechanically boost per-share metrics under a 75% distribution framework. However, valuation multiples remain constrained near 10.7 times normalized underlying earnings rather than experiencing dramatic re-rating, as cyclical commercial lines softening and French sovereign spread volatility counterbalance technical underwriting margin expansion.

Key insights

Fixed-income duration rollover generates enduring recurring investment spread that outlasts central bank policy tightening, establishing a defensive floor under operating cash generation.
Divestment of volatile asset management concentrates capital into high-retention health and retail protection lines, reducing equity beta while freeing substantial upstream cash.
Long-tail casualty reserve adequacy and European sovereign spread sensitivity represent decisive risk vectors that could restrict discretionary share repurchases during macro shocks.

Deep Dive

The market consensus treats AXA as an unexciting European financial utility shackled to continental macroeconomic stagnation, French sovereign debt risk, and cyclical insurance pricing. Sell-side commentary focuses on potential commercial rate softening and weather claims volatility, anchoring valuation to depressed single-digit earnings multiples while overlooking the compounding power of fixed-income float reinvestment and disciplined capital return programs.

Paywalled preview begins: Deep Dive

From this section to the end-of-preview notice below, research is provided as simplified HTML text and tables. Full access provides the complete interactive interface, charts and additional datasets.

Alpha Gap & Repricing Catalysts

Where the published AI consensus diverged from the market narrative

Market narrative

Alpha gap

The crowd underestimates value through persistent underpricing. Consensus fixates on headline revenue lethargy and mistaken trailing price-to-earnings metrics, failing to recognize that shedding capital-intensive asset management permanently de-risked the franchise. The market overlooks the compounding velocity of fixed-income float reinvestment at 3.5% to 4.5% yields, which, combined with 25 billion euros in organic cash upstreams and systematic share retirement, compounds underlying EPS well above top-line growth.

Repricing catalyst

Operational delivery under the 2027-2029 strategic roadmap will trigger market repricing. As consecutive earnings reports prove that underlying EPS compounds at 7% to 9% alongside sustained 75% cash distributions and robust Solvency II capital generation above 25 points, institutional investors will be forced to reprice the stock, narrowing the unwarranted valuation discount against international composite insurance peers.

Published consensus context

Macro regime alignment

The prevailing monetary regime is an overall positive tailwind. Sustained higher European sovereign and corporate yields systematically expand recurring investment income across AXA's multi-hundred-billion-euro general account fixed-income portfolio. While persistent inflation exerts upward pressure on automotive replacement parts and medical claims costs, dynamic contract repricing and strong regulatory solvency comfortably insulate group profitability.

Published consensus context

Advisor disagreement

The primary disagreement across reports centers on valuation multiple expansion versus multiple stagnation. Optimistic perspectives project multiples re-rating toward 12x earnings based on capital-light de-risking and 75% distribution yields. In contrast, cautious views argue that softening commercial lines pricing at AXA XL and structural French sovereign spread risk permanently cap the multiple near 10.5x, making EPS compounding through buybacks the sole driver of price appreciation. A secondary dispute involves data freshness, as several models mistakenly treat non-recurring 2025 divestment gains as recurring earnings. Monitoring 2027 commercial renewal rates and French OAT spreads will resolve this debate.

Published scenario analysis

Base-case forces, risks, and opportunities

Top drivers and tailwinds

Fixed-income float reinvestment yield expansion: Structurally elevated sovereign and corporate bond yields across Europe enable AXA to roll over its massive general account fixed-income float at yields between 3.5% and 4.5%. This persistent portfolio turnover steadily widens net investment margins, directly expanding recurring net investment income and establishing a durable multi-year foundation for underlying earnings growth. Expected impact: +16%.
Programmatic capital return and share retirement: Management's commitment to return 75% of underlying earnings via ordinary dividends and recurring annual share repurchases mechanically shrinks the equity base. Supported by planned 25 billion euros in cumulative organic cash remittances through 2029, systematic share cancellations compound per-share earnings, providing firm downside price support and driving intrinsic value accretion. Expected impact: +15%.
Technical underwriting discipline and mix shift: Strategic portfolio repositioning away from volatile catastrophe reinsurance toward capital-light retail, employee benefits, and commercial specialty lines defends technical underwriting margins. Pruning unprofitable risks and enforcing strict attachment points preserves property and casualty combined ratios near 91%, insulating cash generation from broader economic deceleration. Expected impact: +12%.
Algorithmic underwriting and claims automation: Enterprise-scale deployment of proprietary artificial intelligence across claims intake, fraud detection, and automated underwriting targets 500 to 700 million euros in annual pre-tax efficiency gains by 2029. Compressing administrative expense ratios and accelerating claims settlement directly enhances operating margins, shielding profitability against secular wage inflation. Expected impact: +9%.

Top frictions and headwinds

Commercial reinsurance pricing cycle softening: Expanding global reinsurance capacity and aggressive broker competition exert downward pressure on commercial property and casualty pricing. Softening rate-on-line trends force AXA XL to voluntarily contract premium volume to protect underwriting integrity, constraining top-line revenue momentum and limiting prospective technical underwriting profit expansion. Expected impact: -10%.
Persistent replacement cost and claims inflation: Elevated supply chain expenses, rising vehicle sensor replacement costs, and sticky medical inflation increase claims severity across retail motor and casualty portfolios. Because policy repricing lags inflation shocks, loss ratios experience frictional compression before annual rate adjustments fully earn through, dampening near-term operating margins. Expected impact: -9%.
Secondary peril climate loss volatility: Increasing frequency of unmodeled secondary climate perils, including severe convective storms, localized hail, and regional European flooding, regularly challenges the normalized 4.5-point natural catastrophe budget. Elevated industry-wide reinsurance retention points force AXA to absorb higher net attritional losses, introducing quarterly earnings volatility. Expected impact: -8%.
European sovereign spread balance sheet friction: Widening French sovereign OAT spreads against German Bunds, driven by European fiscal deficits and political friction, generate mark-to-market fluctuations across AXA's fixed-income holdings. Although liability matching mitigates default risk, spread volatility erodes regulatory own funds and elevates risk premiums, capping valuation multiples. Expected impact: -7%.

Tail risks

European sovereign debt spread crisis dislocation: Severe political gridlock or credit downgrades in France could blow out sovereign bond spreads beyond 150 basis points against German Bunds. Mark-to-market depreciation across AXA's domestic sovereign debt holdings would compress Solvency II own funds below 185%, forcing management to suspend discretionary share buybacks to preserve capital. Probability: +25%. Expected impact: -24%.
Multi-region megacatastrophe cluster shock: A catastrophic concurrence of major Atlantic Category 5 hurricanes and severe European winter windstorms within a single quarter could exhaust external reinsurance retrocession attachments. Net catastrophe claims exceeding 2.5 billion euros above budget would erase annual underwriting profits, impair regulatory capital, and temporarily freeze shareholder distributions. Probability: +21%. Expected impact: -22%.

Tail opportunities

Solvency II regulatory capital liberation: Implementation of the European Solvency II revision Directive could inject up to 17 percentage points into AXA's solvency ratio by lowering liability risk margins. Freeing approximately 3.5 to 4.0 billion euros in surplus capital would enable the board to execute an exceptional special buyback, driving accelerated per-share intrinsic value appreciation. Probability: +34%. Expected impact: +19%.
Specialty insurance market hyper-hardening surge: An unexpected cluster of complex geopolitical marine transit interdictions or severe critical infrastructure cyber disruptions could trigger an acute global specialty capacity squeeze. Leveraging its robust balance sheet and underwriting expertise, AXA XL could enforce double-digit rate hikes, expanding technical underwriting margins and return on equity above 18%. Probability: +27%. Expected impact: +18%.

What to monitor

Thesis watchpoints

-- Solvency II ratio sustaining above 215% alongside annual subsidiary cash remittances exceeding 7.0 billion euros through 2027 confirms organic capital strength.

Key insights

Property and casualty undiscounted combined ratio deteriorating above 92.5% across two consecutive half-year reports signals claims inflation outrunning pricing discipline.
French ten-year OAT spread widening sustainably beyond 110 basis points over German Bunds requires immediate reassessment of portfolio capital solvency flexibility.

Company Financial Analysis

AXA Earnings and Financials Analysis by AI

Financial figures available as of Sep 20, 2026. Only filings and source records available by this analysis date are included.

Earnings and financials

AI Review

AXA's operating earnings show steady, high-quality growth driven by disciplined insurance underwriting and higher investment yields. In 2025, underlying earnings expanded to 8.4 billion euros, while first-half 2026 delivered an 8% increase in underlying earnings per share to 2.19 euros. Headline net income of 9.80 billion euros in 2025 was boosted by a one-off 2.2-billion-euro gain from selling AXA Investment Managers for 5.1 billion euros, which retail investors should not confuse with recurring profit. Looking past divestment gains reveals a cleaner, more predictable earnings engine. Operating cash flows remain robust, funding regular dividends and share buybacks while underlying businesses compound at 7% to 9% annually.

Revenue, earnings, and cash flow

The table compares up to five fiscal years of revenue, net income, and free cash flow available to this analysis.

Revenue, net income, and free cash flow history
Fiscal year	Revenue	Net income	Free cash flow
2025	EUR 109.2B	EUR 9.8B	EUR 21.1B
2024	EUR 107.9B	EUR 7.9B	EUR 11.1B
2023	EUR 100.2B	EUR 7.2B	EUR 5.2B
2022	EUR 103.7B	EUR 6.7B	EUR 7.5B
2021	EUR 122.2B	EUR 7.3B	EUR 6.2B

Valuation context: historical P/E

The table compares up to five fiscal years of point-in-time valuation evidence available to this analysis.

Historical price-to-earnings ratios
Fiscal year	P/E	Earnings basis	Currency basis	Ticker / reporting
2025	4.7x	TTM	Native	EUR / EUR
2024	5.0x	TTM	Native	EUR / EUR
2023	6.4x	TTM	Native	EUR / EUR
2022	9.1x	Annual	Native	EUR / EUR
2021	8.6x	Annual	Native	EUR / EUR

P/E uses historical market capitalization and earnings known at each period. Cross-currency observations are normalized to USD using point-in-time FX rates.

Profitability and margins

AI Review

Profitability margins have stabilized at healthy levels, with the Property and Casualty combined ratio holding firm near 90.1% in the first half of 2026. Premium rate adjustments in retail motor and home lines have successfully kept pace with inflation in spare parts and medical care costs. Simultaneously, Life and Health profitability expanded by 11%, supported by strong corporate employee protection demand. With maturing bond investments reinvesting at higher interest rates, AXA generates an underlying return on equity between 15% and 17%, decoupling profitability from volatile financial market swings.

The table compares up to five fiscal years of operating income and reported profitability margins.

Operating income and margin history
Fiscal year	Operating income	Operating margin	Net margin
2025	EUR 10B	9.2%	9.0%
2024	EUR 10B	9.3%	7.3%
2023	EUR 8.4B	8.4%	7.2%
2022	EUR 9.3B	9.0%	6.4%
2021	EUR 9.5B	7.8%	6.0%

Balance sheet and leverage

AI Review

AXA maintains an exceptionally solid balance sheet, anchored by a Solvency II regulatory capital ratio of 218% as of June 30, 2026. This buffer sits comfortably above management's 190% operating minimum, providing an effective shield against financial market turbulence and underwriting claims shocks. Financial debt gearing stands prudently at 21.7%, supported by strong interest coverage of roughly 17 times. The primary vulnerability to monitor is not corporate debt but the portfolio's holdings of French sovereign bonds, where widening European interest rate spreads can temporarily reduce accounting capital reserves.

The table compares up to five fiscal years of debt, liquidity, net cash or debt, and current-ratio evidence.

Balance sheet leverage and liquidity history
Fiscal year	Total debt	Cash + short-term investments	Net cash / (debt)	Current ratio
2025	EUR 61.9B	EUR 22.2B	EUR 39.6B net debt	0.10x
2024	EUR 62.1B	EUR 333.6B	EUR 43.2B net debt	24.30x
2023	EUR 59.5B	EUR 320.1B	EUR 34.6B net debt	0.42x
2022	EUR 63.7B	EUR 323.7B	EUR 37.6B net debt	171.08x
2021	EUR 57.2B	EUR 25.1B	EUR 32.2B net debt	269.37x

Net debt below zero is displayed as net cash. Current ratio is current assets divided by current liabilities.

Capex and investment intensity

AI Review

AXA operates an asset-light business model where physical capital expenditure absorbs less than 0.5% of annual revenues. Rather than spending heavily on physical infrastructure or industrial equipment, management concentrates capital investment on software, digital underwriting tools, and claims automation, targeting 500 to 700 million euros in annual efficiency gains by 2029. This low physical investment requirement allows virtually all operating profits to convert directly into distributable cash. By avoiding expensive acquisitions, management can channel billions into share repurchases and progressive dividends without straining company resources.

The table compares up to five fiscal years of capital expenditure and research-and-development investment.

Capital expenditure and research and development history
Fiscal year	Capital expenditure	R&D spend
2025	EUR 428M	--
2024	EUR 476M	--
2023	EUR 427M	--
2022	EUR 353M	--
2021	EUR 350M	--

Immutable published data

Averaged consensus horizons

The table preserves this publication's original rating, return, and advisor-agreement measurements by forecast horizon.

Horizon	Rating	Score incl. dividends	Compounded return incl. dividends	Direction agreement	Snapshot
1Y	BUY	253	+13.5%	Not available	ORIGINAL
5Y	BUY	230	+79.7%	Not available	ORIGINAL

Averaged consensus scenarios

The table outlines the frozen bear, consensus, and bull price scenarios for each published forecast period.

Period	Date	Bear case	Consensus	Bull case	AI Advisors
+3M	December 18, 2026	44.28	45.82	46.07	14
+6M	March 18, 2027	46.5	47.48	47.91	14
+9M	June 18, 2027	45.1	47.32	48.87	14
+1Y	September 18, 2027	46.51	48.73	49.85	14
+15M	December 18, 2027	46.98	49.85	51.33	14
+18M	March 18, 2028	48.39	51.56	53.38	14
+21M	June 18, 2028	46.94	51.42	53.93	14
+2Y	September 18, 2028	47.88	52.74	55.53	14
+27M	December 18, 2028	48.35	53.88	57.2	14
+30M	March 18, 2029	49.8	55.69	59.48	14
+33M	June 18, 2029	48.81	55.6	59.48	14
+3Y	September 18, 2029	49.79	57.03	61.27	14
+39M	December 18, 2029	50.28	58.26	63.11	14
+42M	March 18, 2030	51.29	60.06	65.63	14
+45M	June 18, 2030	49.75	59.93	66.29	14
+4Y	September 18, 2030	50.74	61.13	68.28	14
+51M	December 18, 2030	51.25	62.4	70.32	14
+54M	March 18, 2031	52.79	64.14	72.43	14
+57M	June 18, 2031	51.73	64.1	72.43	14
+5Y	September 18, 2031	52.77	65.48	74.61	14

Frozen comparison context

SPDR S&P 500 ETF Trust forecast context

The benchmark definition and forecast path are frozen with this publication so future benchmark changes do not rewrite the historical comparison.

Benchmark snapshot: 761.69 on September 18, 2026

Period	Date	Bear case	Consensus	Bull case
+3M	December 18, 2026	723.6055	750.2647	769.3069
+6M	March 18, 2027	701.8973	736.44	784.693
+9M	June 18, 2027	695.1	743.3975	808.2338
+1Y	September 18, 2027	681.198	755.1476	816.3162
+15M	December 18, 2027	688.01	776.2182	840.8057
+18M	March 18, 2028	701.7702	787.1259	857.6218
+21M	June 18, 2028	722.8233	802.8344	883.3504
+2Y	September 18, 2028	730.0515	812.0465	892.1839
+27M	December 18, 2028	751.9531	839.1839	927.8713
+30M	March 18, 2029	766.9921	850.5008	946.4287
+33M	June 18, 2029	782.332	872.3935	965.3573
+3Y	September 18, 2029	790.1553	885.5111	975.0109
+39M	December 18, 2029	805.9584	909.5618	1,004.2612
+42M	March 18, 2030	822.0776	916.132	1,024.3464
+45M	June 18, 2030	830.2984	936.5109	1,055.0768
+4Y	September 18, 2030	830.2984	947.3438	1,065.6276
+51M	December 18, 2030	855.2073	969.5876	1,097.5964
+54M	March 18, 2031	872.3114	979.9863	1,119.5483
+57M	June 18, 2031	889.7577	999.6043	1,141.9393
+5Y	September 18, 2031	898.6553	1,011.7644	1,153.3587

Frozen comparison context

EURUSD.FOREX forecast context

The batch's original direct_listing_to_usd path is preserved for transparent interpretation of USD-normalized returns.

FX snapshot: 1.15 on September 18, 2026

Period	Date	Bear case	Consensus	Bull case
+3M	December 18, 2026	1.127	1.136	1.1385
+6M	March 18, 2027	1.1045	1.1255	1.1385
+9M	June 18, 2027	1.0934	1.1272	1.1499
+1Y	September 18, 2027	1.0934	1.1312	1.1614
+15M	December 18, 2027	1.1044	1.1401	1.173
+18M	March 18, 2028	1.0824	1.1452	1.1847
+21M	June 18, 2028	1.0715	1.151	1.1966
+2Y	September 18, 2028	1.0823	1.1584	1.2085
+27M	December 18, 2028	1.0931	1.1617	1.2085
+30M	March 18, 2029	1.0822	1.1694	1.2206
+33M	June 18, 2029	1.0713	1.1719	1.2328
+3Y	September 18, 2029	1.0713	1.1763	1.2328
+39M	December 18, 2029	1.0713	1.1781	1.2452
+42M	March 18, 2030	1.082	1.1832	1.2452
+45M	June 18, 2030	1.0712	1.1867	1.2576
+4Y	September 18, 2030	1.0605	1.1894	1.2699
+51M	December 18, 2030	1.0605	1.1887	1.2826
+54M	March 18, 2031	1.0711	1.1913	1.2826
+57M	June 18, 2031	1.0818	1.1971	1.2826
+5Y	September 18, 2031	1.0818	1.1964	1.2955

The Titan

The Anthropologist

Gemini 3.8 Flash

Weight3.8/100

This submission features compelling narrative prose on yield curve reflation but relies on unverified trailing valuation metrics and downplays the regulatory capital drag resulting from subordinated debt grandfathering expiration.

Skip to references

Research Provenance

References & Context

This AXA consensus analysis combines structured market evidence with independent AI-agent forecasts. External references below are limited to sources recorded by the researcher agents for this forecast batch.

Primary analysis inputs

iPulse AI Multi-Agent Forecasts — independent analyst personas, model outputs, and consensus synthesis.
iPulse AI Global Events Context — macroeconomic, geopolitical, regulatory, and industry-event context.
Structured market history — prices, distributions, volatility, identifiers, and listing metadata.
Company earnings and financial statements — revenue, profitability, balance-sheet, cash-flow, and investment trends.
Researcher web evidence — public sources consulted to challenge and contextualize the forecast thesis.

Independent AI Advisor panel

AI Advisors: 14
AI Researchers: 11
AI Thinkers: 3

Sources retained from AI Researcher searches

Asset-specific · Researcher web

Showing the top 15 of 41 deduplicated sources retained for this batch.

And 26 more sources were used and retained in the batch inventory.

Context retained with this Consensus

The same public-safe market, global-event, and fundamental context supplied to the AI Advisor panel.

Global context snapshot

2025 Full-Year Global Market and World-Events Context

Download Archived Snapshot

Coverage 2025-01-01 to 2025-12-31 · Knowledge cutoff 2025-12-31

This full-year context package covers the principal geopolitical, economic, monetary-policy, technology, trade, energy, and institutional developments that shaped global markets during 2025. It gives the forecasting model a chronological account of major world events together with their likely transmission into growth, inflation, interest rates, supply chains, commodities, currencies, public markets, and sector-level investment conditions.

The package also includes monthly and quarterly macroeconomic and cross-asset reference tables spanning US and international growth, central-bank policy, sovereign yields, major equity indices, foreign exchange, energy, industrial and precious metals, and digital assets. Quarterly and full-year high-impact summaries are integrated; monthly quantitative series remain working values pending final audit, and that qualification is part of the preserved context.

Top 3 market shifts from 2025 Full-Year Global Market and World-Events Context
Top 3 Market Shifts From File	Date	Status
DeepSeek shock and AI economics reset	2025-01-27	OPEN ENDED TREND
US tariff regime escalation and trade-system rupture	2025-02-01	ACTIVE POLICY REGIME
Federal Reserve easing cycle after a prolonged hold	2025-09-17	ACTIVE POLICY REGIME

Representative Sources of the Context File

Federal Reserve US Bureau of Labor Statistics US Bureau of Economic Analysis US Treasury US Energy Information Administration Reuters World Associated Press World News BBC World

And more sources from the retained context package.

2026 Year-to-Date Global Market and World-Events Context Through September 20

Download Archived Snapshot

Coverage 2026-01-01 to 2026-09-20 · Knowledge cutoff 2026-09-20

January 1-September 20, 2026: monetary tightening, energy security, trade restrictions, AI financing and divergent growth; five leading market themes.

Fed raised rates to 3.75%-4.00%; ECB hike is in force and BOJ increase starts September 24. Markets through September 18, bitcoin through September 19.

Top 3 market shifts from 2026 Year-to-Date Global Market and World-Events Context Through September 20
Top 3 Market Shifts From File	Date	Status
Renewed monetary tightening amid persistent inflation	2026-01-30	ACTIVE POLICY REGIME
Iran/Hormuz conflict and wider energy-security disruption	2026-02-28	ONGOING
Tariff legal reset and strategic supply restrictions	2026-02-20	ACTIVE POLICY REGIME

Representative Sources of the Context File

Federal Reserve US Bureau of Labor Statistics European Central Bank International Monetary Fund Reuters World Associated Press World News

And more sources from the retained context package.

Fundamental context

Income statement

8 fields

depreciationAndAmortization · ebit · ebitda · grossProfit · +4 more fields

Balance sheet

12 fields

cash · commonStockSharesOutstanding · longTermDebt · netDebt · +8 more fields

Cash flow

5 fields

capitalExpenditures · dividendsPaid · freeCashFlow · salePurchaseOfStock · +1 more field

annual: 2014-12-31–2025-12-31, 12 periods; quarterly: 2023-12-31–2026-06-30, 6 periods

Currencies cited: EUR, USD (quote EUR; primary reporting EUR; converted/valuation USD).

End of the paywalled preview

The excerpt from Deep Dive to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.

Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.

Additional with full access

Individual AI Advisor reports
- Separate investment theses, scenarios, factors, risks and opportunities
- Quarterly forecast events and supporting citations
- Published advisor configuration snapshots
Interactive research tools
- Zoomable forecast and benchmark comparisons
- Currency and dividend assumptions
- Additional datasets and eligible historical research

Explore complete public research examples

These public assets show the complete AI Consensus research. Their findings concern those assets, not this report.